| |
| |
|
| Insider
Information: |
Fenimore Christopher R. |
| Relationship: |
SVP Finance & CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
14,372 |
|
|
Indirect Shares
|
10,059 |
|
|
| Direct
Value |
$13,986,256 |
|
|
|
Indirect Value
|
$9,789,016 |
|
|
| Total
Shares |
24,431 |
|
|
| Total
Value |
$23,775,272 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 2.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
SVP Finance & CFO |
2024-02-09 |
14,372 |
2024-02-09 |
10,059 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2024-01-23 |
4 |
D |
$948.50 |
$7,179,197 |
D/D |
(7,569) |
19,291 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2024-01-03 |
4 |
D |
$912.30 |
$6,853,198 |
D/D |
(7,512) |
16,860 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2022-03-31 |
4 |
D |
$700.99 |
$6,066,367 |
D/D |
(8,654) |
24,771 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2021-08-20 |
4/A |
D |
$664.85 |
$5,796,827 |
D/D |
(8,719) |
19,020 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2024-01-03 |
4 |
OE |
$399.66 |
$4,776,650 |
D/D |
10,000 |
20,329 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2024-01-23 |
4 |
OE |
$399.66 |
$4,776,650 |
D/D |
10,000 |
22,874 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2024-02-09 |
4 |
S |
$950.49 |
$4,689,320 |
D/D |
(4,919) |
14,372 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2023-08-23 |
4 |
D |
$842.66 |
$4,380,147 |
D/D |
(5,198) |
20,942 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2022-04-08 |
4 |
D |
$736.21 |
$4,127,193 |
D/D |
(5,606) |
26,615 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2020-07-20 |
4 |
D |
$655.57 |
$4,124,191 |
D/D |
(6,291) |
18,986 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2022-03-31 |
4 |
OE |
$270.43 |
$3,815,640 |
D/D |
12,000 |
31,628 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2021-08-23 |
4 |
AS |
$655.00 |
$3,133,037 |
D/D |
(4,781) |
27,739 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2023-08-23 |
4 |
OE |
$399.66 |
$2,797,620 |
D/D |
7,000 |
26,140 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2022-04-08 |
4 |
OE |
$270.43 |
$2,713,542 |
D/D |
7,450 |
30,066 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2023-02-03 |
4 |
D |
$774.29 |
$2,544,317 |
D/D |
(3,286) |
20,295 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2022-10-03 |
4 |
AS |
$724.00 |
$2,422,504 |
D/D |
(3,346) |
18,269 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2021-08-20 |
4 |
OE |
$179.13 |
$2,418,255 |
D/D |
13,500 |
32,520 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2020-07-21 |
4 |
AS |
$636.56 |
$2,381,317 |
D/D |
(3,709) |
17,501 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2023-12-12 |
4 |
D |
$856.71 |
$2,186,324 |
D/D |
(2,552) |
18,750 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2020-06-15 |
4 |
D |
$587.90 |
$2,157,593 |
D/D |
(3,670) |
16,653 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2020-06-16 |
4 |
AS |
$581.40 |
$2,101,215 |
D/D |
(3,556) |
15,277 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2023-12-27 |
4 |
AS |
$856.71 |
$2,097,226 |
D/D |
(2,448) |
14,372 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2020-07-20 |
4 |
OE |
$52.03 |
$1,907,015 |
D/D |
12,224 |
21,210 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2023-03-23 |
4 |
AS |
$806.47 |
$1,767,782 |
D/D |
(2,192) |
18,409 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2023-12-21 |
4 |
AS |
$843.79 |
$1,417,934 |
D/D |
(1,680) |
17,070 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
